Widening the Therapeutic Window in The Management of Parkinson’s Disease

Opinion
Video

Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.

Timecodes:

1:20 Long-term challenges

2:58 Fluctuations in benefits

6:35 Therapeutic window

11:40 Amantadine ER for PD

14:33 Dyskinesia and treatment

18:18 Amantadine patients

23:14 Amantadine formulations

27:59 Early treatment & future

Recent Videos
Kelly Papesh, DNP, APRN, FNP-BC
Patricia Clark, CNP
Michael Soileau, MD, FAAN
David Shprecher, DO, MSci, FAAN
Anvi Gadani, MD
Michael Soileau, MD, FAAN
Patricia Clark, CNP
Kelly Papesh, DNP, APRN, FNP-BC
Related Content
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism

NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism

Isabella Ciccone, MPH
July 24th 2024
Article
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM ;NeurologyLive® Staff
April 9th 2024
Podcast
A Comprehensive Program to Enhance Inpatient Care for Patients With Parkinson Disease

A Comprehensive Program to Enhance Inpatient Care for Patients With Parkinson Disease

Isabella Ciccone, MPH
Published: July 22nd 2024 | Updated: July 24th 2024
Article
Dyskinesia: Importance of Giving Patients More Good “On- Time" in Parkinson’s Disease

Dyskinesia: Importance of Giving Patients More Good “On- Time" in Parkinson’s Disease

Stuart H. Isaacson, MD, FAAN;Rajesh Pahwa, MD;Fiona Gupta, MD
April 5th 2024
Podcast
Understanding the Significant Role of Secondary Symptoms of Parkinson Disease

Understanding the Significant Role of Secondary Symptoms of Parkinson Disease

Marco Meglio
July 15th 2024
Article
NeuroVoices: Kelly Papesh, DNP, APRN, FNP-BC, on Understanding Patient Silence for Movement Disorder Concerns in the Clinical Setting

NeuroVoices: Kelly Papesh, DNP, APRN, FNP-BC, on Understanding Patient Silence for Movement Disorder Concerns in the Clinical Setting

Isabella Ciccone, MPH
Published: July 10th 2024 | Updated: July 10th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.